Krispy Kreme Valuation
Is DNUT * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DNUT * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DNUT * (MX$224.27) is trading above our estimate of fair value (MX$77.6)
Significantly Below Fair Value: DNUT * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DNUT *?
Other financial metrics that can be useful for relative valuation.
What is DNUT *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$2.02b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.1x |
Enterprise Value/EBITDA | 22.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does DNUT *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.3x | ||
ALSEA * Alsea. de | 0.8x | 9.3% | Mex$57.4b |
CMR B CMR. de | 0.2x | n/a | Mex$822.5m |
POSADAS A Grupo Posadas. de | 1.6x | n/a | Mex$14.3b |
RLH A RLH Properties. de | 2.6x | n/a | Mex$19.2b |
DNUT * Krispy Kreme | 1.2x | 8.9% | Mex$2.0b |
Price-To-Sales vs Peers: DNUT * is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (1.3x).
Price to Earnings Ratio vs Industry
How does DNUT *'s PE Ratio compare vs other companies in the South American Hospitality Industry?
Price-To-Sales vs Industry: DNUT * is expensive based on its Price-To-Sales Ratio (1.2x) compared to the South American Hospitality industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is DNUT *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate DNUT *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$224.27 | Mex$278.21 +24.1% | 16.1% | Mex$365.26 | Mex$215.84 | n/a | 10 |
May ’25 | Mex$230.00 | Mex$290.48 +26.3% | 16.7% | Mex$376.97 | Mex$222.76 | n/a | 9 |
Apr ’25 | n/a | Mex$267.16 0% | 16.6% | Mex$365.89 | Mex$216.21 | n/a | 9 |
Mar ’25 | n/a | Mex$253.28 0% | 9.8% | Mex$306.86 | Mex$221.62 | n/a | 9 |
Feb ’25 | n/a | Mex$274.00 0% | 15.8% | Mex$363.69 | Mex$225.14 | n/a | 10 |
Jan ’25 | n/a | Mex$269.12 0% | 17.4% | Mex$360.20 | Mex$222.98 | n/a | 9 |
Dec ’24 | n/a | Mex$277.48 0% | 16.8% | Mex$370.62 | Mex$229.43 | n/a | 9 |
Nov ’24 | n/a | Mex$287.85 0% | 15.8% | Mex$379.12 | Mex$234.70 | n/a | 9 |
Oct ’24 | n/a | Mex$296.20 0% | 13.8% | Mex$371.35 | Mex$247.57 | n/a | 10 |
Sep ’24 | n/a | Mex$289.17 0% | 12.9% | Mex$357.21 | Mex$238.14 | n/a | 10 |
Aug ’24 | n/a | Mex$300.85 0% | 11.2% | Mex$354.94 | Mex$236.63 | n/a | 10 |
Jul ’24 | Mex$240.00 | Mex$304.61 +26.9% | 11.6% | Mex$361.40 | Mex$240.93 | n/a | 10 |
Jun ’24 | n/a | Mex$314.01 0% | 11.6% | Mex$368.62 | Mex$245.75 | n/a | 9 |
May ’24 | n/a | Mex$295.61 0% | 16.5% | Mex$377.50 | Mex$233.69 | Mex$230.00 | 9 |
Apr ’24 | n/a | Mex$297.19 0% | 16.9% | Mex$387.37 | Mex$239.80 | n/a | 9 |
Mar ’24 | n/a | Mex$284.42 0% | 14.9% | Mex$387.85 | Mex$240.10 | n/a | 10 |
Feb ’24 | Mex$255.00 | Mex$287.17 +12.6% | 15.5% | Mex$394.15 | Mex$244.00 | n/a | 10 |
Jan ’24 | n/a | Mex$294.15 0% | 16.1% | Mex$408.11 | Mex$223.49 | n/a | 11 |
Dec ’23 | n/a | Mex$306.38 0% | 13.7% | Mex$405.58 | Mex$241.42 | n/a | 11 |
Nov ’23 | n/a | Mex$315.81 0% | 16.1% | Mex$421.69 | Mex$240.97 | n/a | 11 |
Oct ’23 | n/a | Mex$316.61 0% | 16.6% | Mex$423.49 | Mex$241.99 | n/a | 10 |
Sep ’23 | Mex$250.00 | Mex$316.61 +26.6% | 16.6% | Mex$423.49 | Mex$241.99 | n/a | 10 |
Aug ’23 | n/a | Mex$348.14 0% | 14.4% | Mex$430.06 | Mex$286.71 | n/a | 10 |
Jul ’23 | Mex$288.98 | Mex$344.51 +19.2% | 14.4% | Mex$425.57 | Mex$283.71 | Mex$240.00 | 10 |
Jun ’23 | Mex$288.98 | Mex$344.51 +19.2% | 14.4% | Mex$425.57 | Mex$283.71 | n/a | 10 |
May ’23 | n/a | Mex$352.01 0% | 15.9% | Mex$460.01 | Mex$280.01 | n/a | 10 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.